{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T14:11:47Z","timestamp":1770819107617,"version":"3.50.1"},"reference-count":28,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal Fran\u00e7ais d'Ophtalmologie"],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1016\/j.jfo.2009.10.001","type":"journal-article","created":{"date-parts":[[2009,11,5]],"date-time":"2009-11-05T07:39:57Z","timestamp":1257406797000},"page":"652-663","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Utilisation du bevacizumab en injection intravitr\u00e9enne dans le traitement du glaucome n\u00e9ovasculaire. \u00c0 propos de 20 cas"],"prefix":"10.1016","volume":"32","author":[{"given":"J.","family":"Douat","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Auriol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Mahieu-Durringer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Anc\u00e8le","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Pagot-Mathis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Mathis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jfo.2009.10.001_bib1","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.preteyeres.2007.06.001","article-title":"Neovascular glaucoma","volume":"26","author":"Hayreh","year":"2007","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.jfo.2009.10.001_bib2","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1056\/NEJMoa032691","article-title":"Bevacizumab plus irinotecan, \ufb02uorouracil, and leucovorin for metastatic colorectal cancer","volume":"350","author":"Hurwitz","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jfo.2009.10.001_bib3","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1210\/er.2003-0027","article-title":"Vascular endothelial growth factor: basic science and clinical progress","volume":"25","author":"Ferrara","year":"2004","journal-title":"Endocr Rev"},{"key":"10.1016\/j.jfo.2009.10.001_bib4","first-page":"289","article-title":"Consensus sur le glaucome n\u00e9ovasculaire","volume":"23","author":"Hamard","year":"2000","journal-title":"J Fr Ophtalmol"},{"key":"10.1016\/j.jfo.2009.10.001_bib5","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0181-5512(06)73754-8","article-title":"Description des pratiques pour la r\u00e9alisation des injections intravitr\u00e9ennes","volume":"29","author":"Korobelnik","year":"2006","journal-title":"J Fr Ophtalmol"},{"key":"10.1016\/j.jfo.2009.10.001_bib6","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1136\/bjo.2006.099598","article-title":"The International Intravitreal Bevacizumab Safety Survey: using the internet to assess drug safety worldwide","volume":"90","author":"Fung","year":"2006","journal-title":"Br J Ophthalmol"},{"issue":"Suppl 3","key":"10.1016\/j.jfo.2009.10.001_bib7","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1159\/000088481","article-title":"Managing patients treated with bevacizumab combination therapy","volume":"69","author":"Gordon","year":"2005","journal-title":"Oncology"},{"key":"10.1016\/j.jfo.2009.10.001_bib8","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1093\/annonc\/mdl161","article-title":"A phase II study of high-dose bevacizumab in combination with irinotecan, 5-fluorouracil, leucovorin, as initial therapy for advanced colorectal cancer: results from the Eastern Cooperative Oncology Group study E2200","volume":"17","author":"Giantonio","year":"2006","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jfo.2009.10.001_bib9","doi-asserted-by":"crossref","unstructured":"The diabetic retinopathy study research g*roup. Preliminary report on effects of photocoagulation therapy. Am J Ophthalmol 1976; 81:383-96.","DOI":"10.1016\/0002-9394(76)90292-0"},{"key":"10.1016\/j.jfo.2009.10.001_bib10","doi-asserted-by":"crossref","unstructured":"The Central Vein Occlusion Study G*roup. Natural history and clinical management of central retinal vein occlusion. Arch Ophthalmol 1997; 115:486-91.","DOI":"10.1001\/archopht.1997.01100150488006"},{"key":"10.1016\/j.jfo.2009.10.001_bib11","doi-asserted-by":"crossref","unstructured":"The Central Vein Occlusion Study G*roup N report. A randomized clinical trial of early panretinal photocoagulation for ischemic central vein occlusion. Ophthalmology 1995; 102:1434-44.","DOI":"10.1016\/S0161-6420(95)30848-2"},{"key":"10.1016\/j.jfo.2009.10.001_bib12","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/BF00920049","article-title":"Argon laser panretinal photocoagulation in ischemic central retinal vein occlusion\u2014a 10-year prospective study","volume":"228","author":"Hayreh","year":"1990","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.jfo.2009.10.001_bib13","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ophtha.2005.10.012","article-title":"Changes in retinal neovascularization after pegaptanib (Macugen) therapy in diabetic individuals","volume":"113","author":"Adamis","year":"2006","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jfo.2009.10.001_bib14","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ajo.2006.02.015","article-title":"Regression of iris neovascularization after intravitreal injection of bevacizumab in patients with proliferative diabetic retinopathy","volume":"142","author":"Oshima","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jfo.2009.10.001_bib15","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.ajo.2006.02.045","article-title":"Intracameral bevacizumab for iris rubeosis","volume":"142","author":"Grisanti","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jfo.2009.10.001_bib16","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/00006982-200603000-00017","article-title":"Rapid improvement of rubeosis iridis from a single bevacizumab (Avastin) injection","volume":"26","author":"Davidorf","year":"2006","journal-title":"Retina"},{"key":"10.1016\/j.jfo.2009.10.001_bib17","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/00006982-200603000-00004","article-title":"Intravitreal bevacizumab (Avastin) treatment of proliferative diabetic retinopathy complicated by vitreous hemorrhage","volume":"26","author":"Spaide","year":"2006","journal-title":"Retina"},{"key":"10.1016\/j.jfo.2009.10.001_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.ophtha.2006.05.064","article-title":"Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy","volume":"113","author":"Avery","year":"2006","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jfo.2009.10.001_bib19","doi-asserted-by":"crossref","first-page":"789","DOI":"10.3129\/i07-176","article-title":"Bevacizumab: the need for controlled studies to move forward","volume":"42","author":"Buys","year":"2007","journal-title":"Can J Ophthalmol"},{"key":"10.1016\/j.jfo.2009.10.001_bib20","doi-asserted-by":"crossref","unstructured":"Diabetic Retinopathy Clinical Research Network, Scott IU, Edwards AR, Beck RW, Bressler NM, Chan CK, et al. A phase II randomized clinical trial of intravitreal bevacizumab for diabetic macular edema. Ophthalmology 2007; 114:1860-7.","DOI":"10.1016\/j.ophtha.2007.05.062"},{"key":"10.1016\/j.jfo.2009.10.001_bib21","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ajo.2007.02.037","article-title":"Intravitreal bevacizumab (Avastin) injection in ocular ischemic syndrome","volume":"144","author":"Amselem","year":"2007","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jfo.2009.10.001_bib22","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.ajo.2006.06.066","article-title":"Intravitreal bevacizumab (Avastin) in the treatment of neovascular glaucoma","volume":"142","author":"Iliev","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jfo.2009.10.001_bib23","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S0161-6420(98)92782-8","article-title":"Increased level of vascular endothelial growth factor in aqueous humor of patients with neovascular glaucoma","volume":"105","author":"Tripathi","year":"1998","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jfo.2009.10.001_bib24","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1001\/archopht.124.3.355","article-title":"Long-term results of Molteno implant insertion in cases of neovascular glaucoma","volume":"124","author":"Every","year":"2006","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jfo.2009.10.001_bib25","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1097\/01.ijg.0000212270.27359.64","article-title":"Trabeculectomy with mitomycin C combined with direct cauterization of peripheral iris in the management of neovascular glaucoma","volume":"15","author":"Elgin","year":"2006","journal-title":"J Glaucoma"},{"key":"10.1016\/j.jfo.2009.10.001_bib26","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1159\/000099248","article-title":"Intravitreal bevacizumab for filtering surgery","volume":"39","author":"Jonas","year":"2007","journal-title":"Ophthalmic Res"},{"key":"10.1016\/j.jfo.2009.10.001_bib27","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1055\/s-2008-1035131","article-title":"Diode laser cyclophotocoagulation in treatment of therapy refractory glaucoma","volume":"211","author":"Schlote","year":"1997","journal-title":"Klin Monatsbl Augenheilkd"},{"key":"10.1016\/j.jfo.2009.10.001_bib28","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1136\/bjo.2007.127142","article-title":"Tractional retinal detachment following intravitreal bevacizumab (Avastin) in patients with severe proliferative diabetic retinopathy","volume":"92","author":"Arevalo","year":"2008","journal-title":"Br J Ophthalmol"}],"container-title":["Journal Fran\u00e7ais d'Ophtalmologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0181551209002988?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0181551209002988?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T19:00:57Z","timestamp":1759258857000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0181551209002988"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11]]},"references-count":28,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["S0181551209002988"],"URL":"https:\/\/doi.org\/10.1016\/j.jfo.2009.10.001","relation":{},"ISSN":["0181-5512"],"issn-type":[{"value":"0181-5512","type":"print"}],"subject":[],"published":{"date-parts":[[2009,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Utilisation du bevacizumab en injection intravitr\u00e9enne dans le traitement du glaucome n\u00e9ovasculaire. \u00c0 propos de 20 cas","name":"articletitle","label":"Article Title"},{"value":"Journal Fran\u00e7ais d'Ophtalmologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfo.2009.10.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}